Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
- PMID: 32412631
- PMCID: PMC7239145
- DOI: 10.1093/eurheartj/ehaa409
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
Erratum in
-
Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the Covid-19 era.Eur Heart J. 2021 Feb 11;42(6):683. doi: 10.1093/eurheartj/ehaa976. Eur Heart J. 2021. PMID: 33351883 Free PMC article. No abstract available.
-
Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.Eur Heart J. 2021 Jan 21;42(4):322. doi: 10.1093/eurheartj/ehaa690. Eur Heart J. 2021. PMID: 33521826 Free PMC article. No abstract available.
Abstract
Aims: To evaluate the impact of the COVID-19 pandemic on patient admissions to Italian cardiac care units (CCUs).
Methods and results: We conducted a multicentre, observational, nationwide survey to collect data on admissions for acute myocardial infarction (AMI) at Italian CCUs throughout a 1 week period during the COVID-19 outbreak, compared with the equivalent week in 2019. We observed a 48.4% reduction in admissions for AMI compared with the equivalent week in 2019 (P < 0.001). The reduction was significant for both ST-segment elevation myocardial infarction [STEMI; 26.5%, 95% confidence interval (CI) 21.7-32.3; P = 0.009] and non-STEMI (NSTEMI; 65.1%, 95% CI 60.3-70.3; P < 0.001). Among STEMIs, the reduction was higher for women (41.2%; P = 0.011) than men (17.8%; P = 0.191). A similar reduction in AMI admissions was registered in North Italy (52.1%), Central Italy (59.3%), and South Italy (52.1%). The STEMI case fatality rate during the pandemic was substantially increased compared with 2019 [risk ratio (RR) = 3.3, 95% CI 1.7-6.6; P < 0.001]. A parallel increase in complications was also registered (RR = 1.8, 95% CI 1.1-2.8; P = 0.009).
Conclusion: Admissions for AMI were significantly reduced during the COVID-19 pandemic across Italy, with a parallel increase in fatality and complication rates. This constitutes a serious social issue, demanding attention by the scientific and healthcare communities and public regulatory agencies.
Keywords: Acute myocardial infarction; COVID-19; Cardiac care units; SARS-CoV2; STEMI.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Figures


Comment in
-
Acute coronary syndrome in the time of the COVID-19 pandemic.Eur Heart J. 2020 Jun 7;41(22):2089-2091. doi: 10.1093/eurheartj/ehaa454. Eur Heart J. 2020. PMID: 32498087 Free PMC article. No abstract available.
-
Reduced hospital admissions for ACS - more collateral damage from COVID-19.Nat Rev Cardiol. 2020 Aug;17(8):453. doi: 10.1038/s41569-020-0409-5. Nat Rev Cardiol. 2020. PMID: 32587344 Free PMC article.
References
-
- Onder G, Rezza G, Brusaferro S.. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; doi: 10.1001/jama.2020.4683. - PubMed
-
- McCloskey B, Zumla A, Ippolito G, Blumberg L, Arbon P, Cicero A, Endericks T, Lim PL, Borodina M; WHO Novel Coronavirus-19 Mass Gatherings Expert Group. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet 2020;395:1096–1099. - PMC - PubMed
-
- Hartikainen TS, Sörensen NA, Haller PM, Goßling A, Lehmacher J, Zeller T, Blankenberg S, Westermann D, Neumann J.. Clinical application of the 4th Universal Definition of Myocardial Infarction. Eur Heart J 2020;doi: 10.1093/eurheartj/ehaa035. - PubMed